These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 20238050)
1. Retinal degeneration in a rat model of Smith-Lemli-Opitz Syndrome: thinking beyond cholesterol deficiency. Fliesler SJ Adv Exp Med Biol; 2010; 664():481-9. PubMed ID: 20238050 [TBL] [Abstract][Full Text] [Related]
2. Light-induced exacerbation of retinal degeneration in a rat model of Smith-Lemli-Opitz syndrome. Vaughan DK; Peachey NS; Richards MJ; Buchan B; Fliesler SJ Exp Eye Res; 2006 Mar; 82(3):496-504. PubMed ID: 16360150 [TBL] [Abstract][Full Text] [Related]
3. Retinal degeneration in a rodent model of Smith-Lemli-Opitz syndrome: electrophysiologic, biochemical, and morphologic features. Fliesler SJ; Peachey NS; Richards MJ; Nagel BA; Vaughan DK Arch Ophthalmol; 2004 Aug; 122(8):1190-200. PubMed ID: 15302661 [TBL] [Abstract][Full Text] [Related]
4. Oxysterols and Retinal Degeneration in a Rat Model of Smith-Lemli-Opitz Syndrome: Implications for an Improved Therapeutic Intervention. Fliesler SJ; Xu L Molecules; 2018 Oct; 23(10):. PubMed ID: 30360379 [TBL] [Abstract][Full Text] [Related]
5. Prevention of Retinal Degeneration in a Rat Model of Smith-Lemli-Opitz Syndrome. Fliesler SJ; Peachey NS; Herron J; Hines KM; Weinstock NI; Ramachandra Rao S; Xu L Sci Rep; 2018 Jan; 8(1):1286. PubMed ID: 29352199 [TBL] [Abstract][Full Text] [Related]
6. Lipid hydroperoxide formation in the retina: correlation with retinal degeneration and light damage in a rat model of Smith-Lemli-Opitz syndrome. Richards MJ; Nagel BA; Fliesler SJ Exp Eye Res; 2006 Mar; 82(3):538-41. PubMed ID: 16199034 [TBL] [Abstract][Full Text] [Related]
7. Lipidomic analysis of the retina in a rat model of Smith-Lemli-Opitz syndrome: alterations in docosahexaenoic acid content of phospholipid molecular species. Ford DA; Monda JK; Brush RS; Anderson RE; Richards MJ; Fliesler SJ J Neurochem; 2008 May; 105(3):1032-47. PubMed ID: 18182048 [TBL] [Abstract][Full Text] [Related]
8. 7-Dehydrocholesterol-derived oxysterols and retinal degeneration in a rat model of Smith-Lemli-Opitz syndrome. Xu L; Sheflin LG; Porter NA; Fliesler SJ Biochim Biophys Acta; 2012 Jun; 1821(6):877-83. PubMed ID: 22425966 [TBL] [Abstract][Full Text] [Related]
11. Abnormal cholesterol biosynthesis as in Smith-Lemli-Opitz syndrome disrupts normal skeletal development in the rat. Kolf-Clauw M; Chevy F; Ponsart C J Lab Clin Med; 1998 Mar; 131(3):222-7. PubMed ID: 9523845 [TBL] [Abstract][Full Text] [Related]
12. Transcriptomic Changes Associated with Loss of Cell Viability Induced by Oxysterol Treatment of a Retinal Photoreceptor-Derived Cell Line: An In Vitro Model of Smith-Lemli-Opitz Syndrome. Pfeffer BA; Xu L; Fliesler SJ Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652836 [TBL] [Abstract][Full Text] [Related]
14. Partial rescue of retinal function and sterol steady-state in a rat model of Smith-Lemli-Opitz syndrome. Fliesler SJ; Vaughan DK; Jenewein EC; Richards MJ; Nagel BA; Peachey NS Pediatr Res; 2007 Mar; 61(3):273-8. PubMed ID: 17314682 [TBL] [Abstract][Full Text] [Related]
16. Ion-current-based proteomic profiling of the retina in a rat model of Smith-Lemli-Opitz syndrome. Tu C; Li J; Jiang X; Sheflin LG; Pfeffer BA; Behringer M; Fliesler SJ; Qu J Mol Cell Proteomics; 2013 Dec; 12(12):3583-98. PubMed ID: 23979708 [TBL] [Abstract][Full Text] [Related]